BioSpace News Archive

If you are trying to land your first position in the life sciences industry, the thought of an interview can be even more overwhelming.

Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline.

AstraZeneca and Merck announced high-level results from the Phase 3 GY004 trial, led by NRG Oncology and sponsored by the U.S. National Cancer Institute, that examined primarily the efficacy and safety of investigational medicine cediranib in combination with LYNPARZA versus platinum-based chemotherapy in patients with platinum-sensitive relapsed ovarian cancer.

Transmission speed of the Covid-19 virus remains difficult to assess, and Castellum is closely following developments.

Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds.

International medical imaging IT and cybersecurity company Sectra has signed a contract with the Swedish healthcare provider Region Halland to deliver its radiology imaging solution as a cloud service.

Pulling no punches, the UCLA Anderson Forecasts for the national, state and global economies take a hard look at the potential impacts of COVID-19.

Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, announced the closing of a $102 million Series C financing.

Mentice AB, a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio.

Agreement Supports Potential of Everads’ Novel Technology and Method for Delivery of Posterior Segment Therapeutics to the Suprachoroidal Space